Stock Rich List
#9299 on the rich list of 14,644 insiders

David Bredt

Chief Scientific Officer at Rapport Therapeutics. Based in Boston, Massachusetts.

$9.3M
in disclosed stock, +$75K (+0.81%) today
Market closed. Prices as of Nov 19, 4:00 PM ET
Rank
9299th of 14,644
Companies held
1
Largest holding
RAPP, 100.0% of total
Latest SEC filing
Feb 19, 2026

What the $9.3M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Rapport Therapeutics RAPP
Common Stock
Directly393,075$23.59$9.3M100.0%Form 4, Feb 19, 2026

Share counts are the amounts David Bredt reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Feb 17, 2026SoldRAPP2,200$29.59$65KView
Feb 17, 2026SoldRAPP5,400$28.95$156KView
Feb 17, 2026SoldRAPP900$28.02$25KView
Jan 15, 2026SoldRAPP8,300$26.83$223KView
Jan 15, 2026SoldRAPP200$27.40$5KView
Dec 31, 2025SoldRAPP6,567$30.05$197KView
Dec 15, 2025SoldRAPP7,704$29.95$231KView
Dec 15, 2025SoldRAPP796$30.68$24KView
Nov 17, 2025SoldRAPP5,344$25.39$136KView
Nov 17, 2025SoldRAPP3,156$24.84$78KView
Oct 15, 2025SoldRAPP1,082$26.16$28KView
Oct 15, 2025SoldRAPP7,418$25.73$191KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
9296Patricia Hemingway Hall
Director, Cardinal Health. Dublin, OH
$9.3M−$208K (−2.19%)
9297Fred Hassan
Director, Precigen. Salt Lake City, UT
$9.3M−$134K (−1.43%)
9298Paul W. Jorgensen
Chief Revenue Officer, Doximity. San Francisco, CA
$9.3M−$329K (−3.42%)
9299David Bredt
Chief Scientific Officer, Rapport Therapeutics. Boston, MA
$9.3M+$75K (+0.81%)
9300Glenn H. Nussdorf
Director, Organogenesis Holdings. Bellport, NY
$9.3M−$752K (−7.50%)
9301Robert J. Chersi
Director, Acadian Asset Management
$9.3M−$391K (−4.05%)
9302John J. Abularrage
Co-Chief Executive Officer, BGC Group. New York, NY
$9.3M−$125K (−1.33%)

Other Rapport Therapeutics insiders

All RAPP insiders

Questions

How much stock does David Bredt own?

David Bredt holds $9,272,639 in listed stock based on SEC filings and current prices, mostly Rapport Therapeutics (RAPP). That ranks 9299th on the Stock Rich List.

Is this David Bredt's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did David Bredt last buy or sell stock?

The most recent open-market trade on file is a sale of 2,200 RAPP shares on Feb 17, 2026 at $29.59.